Cargando…
Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release
Skin reactions at the infusion site are a common side effect of continuous subcutaneous insulin infusion therapy. We hypothesized that local skin complications are caused by components of commercial insulin formulations that contain phenol or m-cresol as excipients. The toxic potential of insulin so...
Autores principales: | Weber, Claudia, Kammerer, Daniel, Streit, Bettina, Licht, Alexander H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598374/ https://www.ncbi.nlm.nih.gov/pubmed/28962351 http://dx.doi.org/10.1016/j.toxrep.2014.11.019 |
Ejemplares similares
-
The Molecular Chaperone α-Crystallin as an Excipient in an Insulin Formulation
por: Rasmussen, Tue, et al.
Publicado: (2010) -
Recent Advances in the Excipients Used in Modified Release Vaginal Formulations
por: Dedeloudi, Aikaterini, et al.
Publicado: (2022) -
The Effect of Formulation Excipients and Thermal Treatment on the Release Properties of Lisinopril Spheres and Tablets
por: Amador Ríos, Zoriely, et al.
Publicado: (2015) -
Investigation of the potential application of sodium bentonite as an excipient in formulation of sustained release tablets
por: Alkrad, Jamal Alyoussef, et al.
Publicado: (2017) -
Excipient-excipient interactions in the development of nanocarriers: an innovative statistical approach for formulation decisions
por: Beraldo-de-Araújo, Viviane Lucia, et al.
Publicado: (2019)